Exceptional Survival Among Kentucky Stage IV Non-small Cell Lung Cancer Patients: Appalachian Versus Non-Appalachian Populations.

Vira PravosudNathan L VanderfordBin HuangThomas C TuckerSusanne M Arnold

Published in: The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association (2020)

Differences in the odds of ES among stage IV NSCLC patients were not related to residence in Appalachian versus non-Appalachian Kentucky. ES was associated with other nongenetic and treatment factors that warrant further investigations.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
small cell lung cancer
peritoneal dialysis
single cell
cell therapy
patient reported outcomes
mesenchymal stem cells
tyrosine kinase
patient reported
replacement therapy
drug induced